Display Settings:

Format

Send to:

Choose Destination

    Mod Rheumatol. 2006;16(3):188-90.

    Drug eruption due to bosentan in a patient with systemic sclerosis.

    Nagai Y, Yamanaka M, Nishimura S, Nakano A, Hasegawa A, Ishikawa O.

    Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showamachi, Maebashi, 371-8511, Japan. yanagai@showa.gunma-u.ac.jp

    We present the case of a 60-year-old female patient with systemic sclerosis complicated by pulmonary hypertension. Ten days after the initiation of treatment with bosentan, high fever and skin eruptions were noted. In the previous reports, the frequency of drug-induced skin eruptions has not been well documented. Since the use of bosentan is expected to increase, we should be aware of the previously unknown adverse effects as well as skin eruptions.

    PMID: 16767560 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Bosentan (Tracleer®)

      Bosentan is used to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs). Bosentan may improve the ability to exercise and slow the worsening of symptoms in patien...